ask="N/A"
ask_size="N/A"
average_daily_volume="985988"
bid="47.52"
bid_size="300"
book_value="10.71"
change="-0.42"
change_from_200_day_moving_average="0.87"
change_from_50_day_moving_average="6.05"
change_from_52_week_high="-30.17"
change_From_52_week_low="18.56"
change_in_percent="-0.83%"
close="49.94"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.09"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.74"
ex_dividend_date="N/A"
float_shares="71077000"
high="51.14"
high_52_weeks="80.11"
last_trade_date="3/7/2017"
last_trade_price="49.94"
last_trade_size="118843"
last_trade_time="4:00pm"
low="49.00"
low_52_weeks="31.38"
market_capitalization="4.30B"
moving_average_200_day="49.07"
moving_average_50_day="43.89"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="49.92"
pe_ratio="N/A"
peg_ratio="-0.21"
percent_change_from_200_day_moving_average="+1.77%"
percent_change_from_50_day_moving_average="+13.79%"
percent_change_from_52_week_high="-37.66%"
percent_change_from_52_week_low="+59.15%"
previous_close="50.36"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.70"
price_per_sales="91.85"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.31"
stock_exchange="NMS"
symbol="ALNY"
volume="656454"
weeks_range_52="31.38 - 80.11"
